Tagged with MENA

Egypt The chairman of EIPICO – Egypt’s largest pharma company by units –, Dr Ahmed Kelani, outlines the company’s ambitious growth strategy, which includes the construction of the first biological & biosimilar production plant in Egypt. The plant is expected to commence production at the end of 2023 and would become…

Algeria A snapshot of Algeria, one of the key countries driving growth in MENA, a region that accounts for just 2 percent of world’s pharma market but that is estimated to reach around USD 60 billion by 2025. Algeria has steadily improved its essential health care services. Hecho conVisme Infographic Maker…

Turkey After its best financial year to date – posting revenues of USD 27.3 billion in 2021 – Gilead has said yes to localization in Turkey. The California-based company, known for its HIV and oncology treatments, announced a USD 60 million investment in Turkey, partnering with local player Pharmactive to produce…

UAE Taher Shams, Zulekha Healthcare Group’s Managing Director, outlines the group’s expansion in UAE and India and its participation in the Dubai Health Authority’s “Dubai Health Experience” medical tourism portal. In addition, he speaks about fears of market saturation in UAE.  We are the shining star in the Middle East, with…

Egypt Four years after Egypt enacted a new universal health law, the country’s pharmaceutical market has consolidated itself as the fastest growing in the Middle East and Africa, far outpacing Saudi Arabia, South Africa, the UAE and Algeria. With USD 6.3 billion in value, Egyptian pharma is about to double its…

MEA The Middle East and Africa (MEA) medtech market is expected to grow from a value of USD 16.6 billion in 2019 to USD 21.8 billion at a CAGR of 3.6 percent by 2027, according to Business Market Insights. Read on for five crucial trends impacting MEA medtech and how the…

Saudi Arabia IQVIA Vice President and General Manager Saudi Arabia & Egypt Mohamed Mostafa gives his expert insights into the transformation of the Saudi pharma market in recent years, covering everything from procurement to regulatory, reimbursement, clinical trials, localisation, health economics, and digitalisation. Mostafa also outlines how IQVIA has adapted its Saudi…

MEA On International Women’s Day 2022, Inna Nadelwais, executive director at Middle East and Africa medtech trade association Mecomed, examines the road still to travel towards true gender parity in the MEA medtech workforce, and why diversity, inclusion, and equality in the workplace benefits all parties.   The MEA region continues…

Global Less than two months passed between the WHO’s official pandemic declaration and remdesivir’s emergency use authorisation in the United States in May 2020. Today, the intravenous antiviral, sold by Gilead Sciences under the brand name Veklury, has generated over USD 8 billion in sales.   Remdesivir’s success as a treatment…

Egypt All the latest news stories from Egypt’s healthcare and life sciences industry, including Egypt’s health insurance authority’s plans to add 100 new medical services, how the COVID-19 Omicron variant threatens to overwhelm the country’s healthcare system, and a new tie-up between Siemens Healthineers and Alameda Group.   Egypt’s health insurance…

MEA The top 10 fastest growing pharma companies in the Middle East and Africa (region) ranked by previous period growth between MAT Q2 2020 and MAT Q2 2021. The list is dominated by regional players including Julphar, Sedico/Acdima and Eva Pharma, but multinational firms are also represented by Gilead Sciences, Takeda,…

Italy The latest news from the Italian healthcare and life sciences industries, including the final piece in Angelini’s updated leadership team; the country’s digital health investment timetable; and the details of Menarini’s Europe commercialisation deal for Karyopharm’s NEXPOVIO in Europe.   Angelini Pharma Appoints Rafal Kaminski as New Chief Scientific Officer…